340B Program
A drug pricing program which allows for Covered Entities to treat low income and uninsured patients
Unfortunately, a program that was designed to benefit the vulnerable is also affected by prevalent amounts of fraud, waste, and abuse.
Manufacturers within the program must provide eligible entities with reduced pricing on medication. Currently there is a reoccurring problem of data consistently being inconsistent.
Manufacturers rely on the policing of pricing to exist with the distributors. The Health Resources and Services Administration has been designated the overseer of this program.
There are now roughly 3 million patients, 150 manufacturers, and over 55,000 covered entities involved with the program.
Partnering with PharmalytIQ means a reduction of hours spent with pricing files, reduction of hassle working on chargebacks and recognizing properly reconciled 340B discount pricing. Through PharmaSee, we can automate the distribution pipeline so that distributors concentrate on their core competency, distribution.
For more information, please visit: https://www.hrsa.gov/opa
Schedule a demo
If you choose to work with us at Pharmalytiq you aren’t just buying software, you are partnering with highly trained professionals who are fully committed to assisting you run your business in the most effective way possible. Reach out to schedule a demo today!